SCHEMBL1483987

SCHEMBL1483987

N#Cc1ccc2cc(-c3ccc(F)nc3)[nH]c2c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK5 Q00535 5/20 0.51
CDK5R1 Q15078 5/20 0.51
CYP19A1 P11511 2/20 0.49
ITK Q08881 3/20 0.48
CYP11B2 P19099 2/20 0.42
RET P07949 1/20 0.40
GSK3B P49841 2/20 0.39
CCNB2 O95067 1/20 0.39
CDK1 P06493 1/20 0.39
CCNB1 P14635 1/20 0.39
GSK3A P49840 1/20 0.39
CCNB3 Q8WWL7 1/20 0.39
KDM1A O60341 1/20 0.39
RIPK1 Q13546 1/20 0.38
CYP11B1 P15538 1/20 0.38
SNCA P37840 1/20 0.38
CSNK1A1 P48729 1/20 0.38
CSNK1D P48730 1/20 0.38
CSNK1G2 P78368 1/20 0.38
PKN1 Q16512 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1484040 0.89 CYP19A1 (0.62) CDK5CDK5R1CYP19A1ITKCYP11B2
SCHEMBL14783606 0.85 CDK5 (0.54) CDK5CDK5R1CYP19A1ITKRET
SCHEMBL1424645 0.82 ITK (0.53) CDK5CDK5R1ITK
SCHEMBL10671177 0.81 CYP19A1 (0.61) CDK5CDK5R1CYP19A1ITKGSK3B
SCHEMBL29651657 0.81 CYP19A1 (0.61) CDK5CDK5R1CYP19A1ITKGSK3B
SCHEMBL31195864 0.81 CDK5 (0.50) CDK5CDK5R1CYP19A1ITKRET
SCHEMBL1421146 0.81 CDK5 (0.48) CDK5CDK5R1CYP19A1ITKRET
SCHEMBL1483705 0.79 CNR1 (0.54) CDK5CDK5R1CYP19A1CYP11B2RET
SCHEMBL12756739 0.77 CYP19A1 (0.58) CYP19A1ITKGSK3B
SCHEMBL1484046 0.76 ITK (0.56) CDK5CDK5R1ITKCCNB2CDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110076230-A1 Novel Substituted Indoles MERCK & CO. INC. 2011-03-31 US claimed
US-20110076230-A1 Novel Substituted Indoles MERCK & CO. INC. 2011-03-31 US disclosed
US-20110076230-A1 Novel Substituted Indoles MERCK & CO. INC. 2011-03-31 US disclosed
US-20110076230-A1 Novel Substituted Indoles MERCK & CO. INC. 2011-03-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110076230-A1 Novel Substituted Indoles APP, BACE1, PSEN1 CDK5 772/4885CDK5R1 1209/4885CYP19A1 3222/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.